
Alphatec Holdings ATEC
$ 13.94
-0.71%
Annual report 2025
added 02-24-2026
Alphatec Holdings P/CF Ratio 2011-2026 | ATEC
Annual P/CF Ratio Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.7 | -34.8 | -23.8 | -20.3 | -14.5 | -23.2 | -7.89 | -1.66 | -2.59 | -1.32 | -19.7 | -3.95 | -29.4 | -26.4 | 35.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 45.7 | -34.8 | -8.54 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Delcath Systems
DCTH
|
14.5 | $ 9.11 | -10.77 % | $ 260 M | ||
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Cognyte Software Ltd.
CGNT
|
14.1 | $ 7.0 | 5.74 % | $ 503 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 4.38 | -4.58 % | $ 163 M | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Apyx Medical Corporation
APYX
|
-8.71 | $ 3.49 | 2.05 % | $ 121 M | ||
|
AxoGen
AXGN
|
1.84 K | $ 31.87 | 2.07 % | $ 1.47 B | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Bio-Rad Laboratories
BIO
|
17.2 | $ 275.33 | 2.19 % | $ 7.77 B | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 40.88 | 2.48 % | $ 6.09 K | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 75.65 | 2.97 % | $ 112 B | ||
|
InMode Ltd.
INMD
|
10.9 | $ 14.0 | 0.29 % | $ 905 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
ClearPoint Neuro
CLPT
|
-52 | $ 14.09 | -7.06 % | $ 381 M | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 45.89 | -0.18 % | $ 1.42 B | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
-7.05 | $ 2.48 | 1.02 % | $ 146 M | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
15.3 | $ 24.18 | 1.09 % | $ 204 M | ||
|
Establishment Labs Holdings
ESTA
|
-20.6 | $ 77.41 | -1.12 % | $ 2.18 B | ||
|
Second Sight Medical Products
EYES
|
-0.0108 | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.53 | -0.3 % | $ 121 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
16.6 | $ 96.27 | 0.06 % | $ 13 B | ||
|
Tandem Diabetes Care
TNDM
|
-130 | $ 26.14 | 0.5 % | $ 1.78 B | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.11 | -2.76 % | $ 1.28 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
14.5 | $ 11.13 | -4.01 % | $ 857 M | ||
|
Cytosorbents Corporation
CTSO
|
-3.77 | $ 0.73 | 2.57 % | $ 39.7 M | ||
|
Inogen
INGN
|
32.9 | $ 6.4 | 6.53 % | $ 151 M | ||
|
IRIDEX Corporation
IRIX
|
-7.13 | $ 1.47 | -2.0 % | $ 23.7 M | ||
|
IRadimed Corporation
IRMD
|
26.1 | $ 102.4 | 1.89 % | $ 1.3 B |